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In this cross-sectional study, we evaluated plasma 8-hydroxydeoxyguanosine (8-OHdG) levels
in patients with colorectal adenoma and cancer, as a surrogate marker of oxidative damage to
deoxyribonucleic acid (DNA). We collected blood samples from 58 patients with adenoma, 32
with early cancer, 25 with advanced cancer, and 36 without polyps or cancer (as controls), and
measured plasma levels of 8-OHdG by enzyme-linked immunosorbent assay. Univariate
analysis by logistic regression showed that an increased level of 8-OHdG was a significant risk
for adenoma [odds ratio (OR) 1.393, 95% confidence interval (CI) 1.008–1.926, p = 0.045]. In
patients with early cancer, univariate analysis revealed significant differences for age, body
mass index (BMI), systolic blood pressure, and 8-OHdG level. Subsequent multivariate
analysis revealed that 8-OHdG [OR 1.627, 95% CI 1.079–2.453, p = 0.020] and BMI [OR
1.283, 95% CI 1.038–1.585, p = 0.021] were significant risk factors for early cancer. However,
8-OHdG was not a significant risk factor for advanced cancer. Our results suggest that an
increased plasma level of 8-OHdG is associated with development of colorectal adenoma and
cancer.
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Introduction
Reactive oxygen species (ROS) are generally produced
endogenously through metabolic processes in living cells.
Excessive energy intake causes excessive production of
nicotinamide adenine dinucleotide and superoxide anions in
mitochondria. These ROS can easily attack proteins, lipids,
sugars, and deoxyribonucleic acid (DNA) [1]. It has been
suggested that DNA damage due to oxidation leads to
tumorigenesis, although the precise mechanisms are still
being investigated [1–4].
Urinary level of 8-Hydroxydeoxyguanosine (8-OHdG)
has been well studied as a marker of oxidized DNA, and
urinary 8-OHdG was also expected to be prospective
biomarker for early prediction of lifestyle related-disease
[5–7]. In addition, so far, urinary levels of 8-OHdG in
patients with various cancers have been reported [8].
Measurement of 8-OHdG in vitro has been performed by
high-performance liquid chromatography (HPLC), but the
procedure is rather complicated. Recently, enzyme-linked
immunosorbent assay (ELISA) kits for 8-OHdG, which are
applicable for not only urine but also blood samples, have
become commercially available [1]. Comparing to urinary
samples, studies of colorectal tumors using blood samples
are not so many. Chang et al. have reported that serum levelsT. Sato et al.
J. Clin. Biochem. Nutr.
60
of 8-OHdG in patients with colorectal cancer are approxi-
mately 4 times higher than those in controls [9]. In contrast,
Dincer  et al. reported that plasma levels of 8-OHdG in
patients with colon cancer were decreased [10].
In the present study, to investigate the association of
oxidative stress with colorectal tumorigenesis, we collected
plasma samples from patients with adenoma, early cancer,
and advanced cancer, and evaluated the link between 8-
OHdG level and the risk of colorectal tumors.
Patients and Methods
Patients
This investigation was a cross-sectional study of hospital-
based patients. From 2004 until 2006, patients who visited
Yamagata University Hospital for colonoscopic examination
were consecutively screened. Patients were enrolled on the
basis of the following inclusion criteria: 1) age of at least 31
years; 2) successful completion of colonoscopic observation
through to the cecum; 3a) histopathological confirmation by
hospital pathologists (for patients with adenoma or cancer)
and 3b) confirmation of lack of obvious polyps upon endo-
scopic examination of the entire colon and rectum (for
controls). The following exclusion criteria were also
applied: 1) previous surgery of the gastrointestinal tract; 2)
presence of inflammatory bowel disease; 3) current or pre-
vious cancer in any organ; and 4) insulin injection therapy.
This study was approved by the Ethics Committee of
Yamagata University Faculty of Medicine. When we had
obtained informed consent from the patients that met our
criteria, fasting blood samples were collected. If the patients
had suspected cancer lesions or advanced cancer lesions,
blood was collected before endoscopic or surgical resection.
Adenomas or cancerous lesions were treated by polypectomy,
endoscopic mucosal resection, laparoscopic surgery, or open
surgery, as appropriate, after which the histopathological
diagnosis was confirmed. Cancer lesions with a depth of
up to T1 were designated as early cancer, according to the
pathologic T factor of the TNM staging system [11].
Measurement
Using plasma samples, we measured the levels of fasting
glucose, triglyceride (TG), high-density lipoprotein choles-
terol (HDL), and 8-OHdG. Before measurement of 8-OHdG,
plasma samples were filtered using membrane filters
(Microcorn YM-10, Nihon Millipore Co Ltd, Tokyo, Japan),
then 8-OHdG was measured by ELISA (high-sensitivity
ELSA kit for 8-OHdG, Nikken Seil Co. Ltd, Shizuoka,
Japan).
We first compared the mean values for controls, adenoma,
early cancer, and advanced cancer. Then, we estimated the
risk of colorectal tumors by logistic regression analysis
(each tumor group versus the control).
Statistics
For all statistical analyses we used the SPSS statistical
software package for Windows version 11.0J (SPSS Inc.
Tokyo, Japan). Distributions were tested by chi-squared
test. Comparisons among groups were tested by ANOVA,
and Dunnett’s test was additionally used if ANOVA revealed
significance (p<0.05). Odds ratios were tested by logistic
regression analysis.
Table 1. Backgrounds of the patients with adenoma, early cancer, and advanced cancer
C. Smokers, current smokers; BMI, body mass index; BP-S, systolic blood pressure; BP-D, diastolic blood pressure; FPG, fasting plasma
glucose; TG, triglyceride; HDL, high-density lipoprotein; 8-OHdG, 8-hydroxydeoxyguanosine. Values were expressed as mean ± SD. In p
values, Gender and smokers were evaluated by chi-squared test, and Age, BMI, BP, FPG, TG, HDL, and 8-OHdG were evaluated by
ANOVA. Additional Dunnett’s test revealed a significant difference in age for advanced cancer (ƒ, p<0.033) and in 8-OHdG of early
cancer (§, p<0.041).
Controls Adenoma Early Cancer Advanced Cancer p value
Number 36 58 32 25
Male/ Female 19/17 40/18 23/9 14/11 NS
Age [years] 61 ± 13 65.1 ± 12.1 67.5 ± 11 67.8 ± 9.6ƒ p = 0.046
C. Smokers (%) 5 (13.9%) 18 (31.0%) 9 (28.1%) 8 (32.0%) NS
BMI [kg/m2]2 3 ± 2.7 22.7 ± 3 24.8 ± 3.2 22.7 ± 3.8 NS
BP-S [mmHg] 123 ± 13 127 ± 14 130 ± 13 128 ± 18 NS
BP-D [mmHg] 73 ± 97 4 ± 10 77 ± 77 6 ± 10 NS
FPG [g/dl] 109 ± 32 106 ± 22 102 ± 15 113 ± 42 NS
TG [mg/dl] 105 ± 78 136 ± 81 128 ± 70 116 ± 53 NS
HDL [mg/dl] 58 ± 18 54 ± 21 48 ± 14 61 ± 83 NS
8-OHdG [ng/10 ml] 3.11 ± 1.3 3.92 ± 1.88 4.17 ± 1.62§ 3.47 ± 1.8 p = 0.046Plasma 8-OHdG in Colorectal Tumors
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Results
Backgrounds of patients and mean values of 8-OHdG
We collected blood samples from 58 patients with
adenoma, 32 with early cancer, 25 with advanced cancer
and 36 without polyps or cancer (as controls).
Clinical backgrounds of patients in the adenoma, cancer,
and control groups are shown in Table 1. There were no
significant differences in the distributions of genders and
current smokers. Mean values of body mass index (BMI),
blood pressure (BP), fasting plasma glucose, TG, or HDL
were not significantly different among the groups. However,
mean age in patients with advanced cancer was significantly
higher than that in the controls (Dunnett’s test, p = 0.033).
Controls had the lowest mean level of 8-OhdG, and patients
with early cancer had the highest, being significantly higher
than in the controls (Dunnett’s test, p = 0.041).
Risks of 8-OHdG for colorectal tumors
In the patients with adenoma, only the 8-OHdG level
[odds ratio (OR) 1.393, 95% confidence interval (CI)
1.008–1.926,  p = 0.045] revealed a significant difference
by univariate analysis with logistic regression (Table 2).
Current smoking, BMI, systolic BP, glucose, and TG were
not recognized as significant risk factors in patients with
adenoma.
In the patients with early cancer, age [OR 1.408, 1.003–
1.096, p = 0.037], BMI [OR 1.236, 95% CI 1.034–1.478,
p = 0.020], systolic BP [OR 1.047, 95% CI 1.004–1.092,
p = 0.03], and 8-OhdG level [OR 1.647, 95% CI 1.143–
2.378,  p = 0.007] showed significant differences by
univariate analysis (Table 3). Multivariate analysis (adjusted
by age, BMI, systolic BP, and 8-OHdG) showed that 8-
OHdG level [OR 1.627, 95% CI 1.079–2.453, p = 0.020]
and BMI [OR 1.283, 95% CI 1.038–1.585, p = 0.021] were
significant risk factors for early cancer.
In the patients with advanced cancer, only age [OR 1.064,
95% CI 1.010–1.121, p = 0.020] revealed a significant odds
ratio by univariate analysis (Table 4). Unlike adenoma and
early cancer, 8-OHdG level was not recognized as a signifi-
cant risk factor for advanced cancer.
Table 2. Logistic regression analysis of factors in colorectal
adenoma
Odds ratios of adenoma vs controls were evaluated by univariate
logistic regression analysis. *p<0.05.
Univariate analysis
OR (95% CI) p value
Gender 1.988 (0.842–4.693) 0.117
Age [years] 1.026 (0.992–1.062) 0.131
C. Smokers 2.790 (0.932–8.350) 0.067
BMI [kg/m2] 0.980 (0.839–1.144) 0.794
BP-S [mmHg] 1.026 (0.992–1.061) 0.133
FPG [g/dl] 0.996 (0.981–1.012) 0.645
TG [mg/dl] 1.006 (0.999–1.013) 0.083
8-OHdG [ng/10 ml] 1.393 (1.008–1.926) 0.045*
Table 3. Logistic regression analysis of factors in colorectal early cancer
Odds ratios of early cancer vs controls were evaluated by univariate and multivariate logistic regression analysis. *p<0.05, **p<0.01.
Univariate analysis Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Gender 2.287 (0.832–6.284) 0.109
Age [years] 1.048 (1.003–1.096) 0.037* 1.039 (0.986–1.094) 0.156
Smoker 2.426 (0.717–8.210) 0.154
BMI [kg/m2] 1.236 (1.034–1.478) 0.020* 1.283 (1.038–1.585) 0.021*
BP-S [mmHg] 1.047 (1.004–1.092) 0.033* 1.028 (0.979–1.080) 0.270
FPG [g/dl] 0.989 (0.967–1.011) 0.313
TG [mg/dl] 1.004 (0.998–1.011) 0.209
8-OHdG [ng/10 ml] 1.649 (1.143–2.378) 0.007** 1.627 (1.079–2.453) 0.020*
Table 4. Logistic regression analysis in colorectal advanced
cancer
Odds ratios of advanced cancer vs controls were evaluated by
univariate logistic regression analysis. *p<0.05.
Univariate analysis
OR (95% CI) p value
Gender 1.139 (0.408–3.176) 0.804
Age [years] 1.064 (1.010–1.121) 0.020*
Smoker 2.918 (0.824–10.330) 0.097
BMI [kg/m2] 0.97 (0.821–1.146) 0.72
BP-S [mmHg] 1.025 (0.989–1.063) 0.182
FPG [g/dl] 1.004 (0.990–10.18) 0.601
TG [mg/dl] 1.003 (0.995–1.010) 0.511
8-OHdG [ng/10 ml] 1.168 (0.834–1.636) 0.367T. Sato et al.
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Discussion
Previously, Chang et al. reported that the serum 8-OHdG
level was about 4-fold higher in colorectal cancer patients
than in controls [9]. Our present data differed in several
respects. Mean levels of 8-OHdG in all three groups
(adenoma, early cancer, and advanced cancer) tended to be
increased from the mean level in the controls. However,
the mean 8-OHdG level was significantly increased only in
early cancer, and was merely 1.3-fold higher than in the
controls. Of course, the studied cohorts in the two investiga-
tions were different. In addition to the mean level, we
examined whether the plasma 8-OHdG level was a risk
factor for colorectal tumors, and found that it was a signifi-
cant risk factor for colorectal adenoma and early cancer.
Previous reports have not calculated the odds ratios for
plasma 8-OHdG in patients with adenoma, early cancer, or
advanced cancer.
Two potential sources of the increased plasma 8-OHdG in
patients with colorectal tumors have been proposed. One is
extra production from tumor tissues. Kondo et al. [12] and
Park et al. [13] reported high levels of 8-OHdG in colorectal
tumor cells obtained by surgical resection. Using immuno-
histochemistry, they also demonstrated strong reactivity for
8-OHdG in colorectal cancer tissues, but not in adenoma
tissues [14]. However, in our present study, the plasma 8-
OHdG level was not so high in patients with advanced
cancer in comparison to patients with early cancer. Thus,
based on our data, it appears that cancer tissues themselves
are not always the major source of increased 8-OHdG levels
in plasma. Of course, we were unable to draw any firm
conclusion from our preliminary data, and a further more
detailed study will be needed. The other potential source of
8-OHdG is general oxidative stress brought about by exces-
sive production of ROS. In this connection, it has been
demonstrated that obesity or metabolic syndrome is strongly
associated with the incidence of colorectal tumors [15]. In
obesity or metabolic syndrome, oxidative stress and 8-
OHdG levels (in blood and urine) are certainly increased
[16–18]. DNA damage caused by oxidative stress probably
plays a role in tumorigenesis caused by obesity or metabolic
syndrome [18]. Our present finding that plasma levels of 8-
OHdG were increased in patients with adenoma and early
cancer would appear to support this hypothesis of tumori-
genesis in relation to obesity or metabolic syndrome. By the
way, oxidative stress can occur not only through excessive
ROS production but also reduction of antioxidative agents.
Chang et al. have reported that antioxidative agents such as
superoxide dismutase are slightly decreased in patients
with colorectal cancer [9]. Future studies of cancer incidence
will therefore also need to focus on antioxidative agents.
In the present study, 8-OHdG was not detected at high
levels in patients with advanced cancer. Possible reasons
could have been decreased energy intake and nutritional
disorders in patients with advanced cancer. In the present
study, age was recognized as a risk factor for advanced
cancer, which seems to be reasonable. Our patients with
advanced cancer had a significantly higher mean age, and
generally 8-OHdG levels increase with age [19]. Therefore,
in the present study, our results must be interpreted carefully
for patients with advanced cancer.
We must discuss about smoking. The plasma 8-OHdG
level is usually increased by smoking [20]. However, in our
study, a current smoking habit was not recognized as a risk
factor for colorectal tumors. A recent meta-analysis has
suggested that smoking increases the risk of colorectal
cancer [21]. Hereafter, therefore, the effects of smoking
must be investigated in more detail.
In conclusion, we have revealed that increased plasma
levels of 8-OHdG are associated with an increased risk of
colorectal adenoma and early cancer. Our data support the
hypothesis that colorectal tumorigenesis is linked to exces-
sive oxidative stress, and suggest that further investigations
of factors such as ROS production are warranted in patients
with obesity and metabolic syndrome.
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